Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023
Renewable Aviation, Renewable Road Transportation and Renewable Polymers and Chemicals business units will be merged into one Renewable Products business unit
Full year net sales are now expected to be in the range of $17 billion and $17.3 billion
Strong cash generation and sustained margins in a weak demand environment
The partnership involves an equity investment and licensing agreement, granting BASF exclusive rights to commercialize CHP solutions for the personal care field
Access to leading maintenance service providers & contractors as well as certified composite repair and reinforcement technologies
The sale is part of Shell’s strategy to high-grade its mobility network
DCW commissions CPVC expansion project
The robust demand emanating from India's pharmaceuticals and chemicals, is poised to propel the plastic packaging industry
The company has posted net profit of Rs.121.01 crores for the half year ended September 30, 2023
DOPO is a multipurpose drone, and with this Type-Certification
This patent is set to maintain its validity for duration of 20 years
The arbitration was filed by the company in 2014 against ONGC for pre-mature termination of the contract
The parties will take steps to withdraw all legal proceedings between the family groups and complete some pending formalities.
The project will be executed over a period of 30 months
Net income attributable to Huntsman of $0 million
The move is aimed at optimizing production costs across its global network
The company has reported total income of Rs. 965.2 crores during the period ended September 30, 2023
The company has reported total income of Rs. 187.12 crores during the period ended September 30, 2023
The company received orders worth Rs. 89,153 crore at the group level during the quarter ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
_195_291.jpg)
